The report highlights UCB's journey to become a patient preferred biopharma leader, encompassing the different dimensions of its business to deliver sustainable value for patients, stakeholders and its people, while navigating the changing ecosystem and sharpening its role in society. The report highlights the company's commitment to innovation, ethical business conduct, diversity and inclusion, and environmental sustainability. Specifically, the report highlights the company's Patient Value Strategy, its New Development Paradigm, its commitment to the United Nations Sustainable Development Goals, and its progress on key environmental targets such as reducing carbon emissions, water consumption, and waste production.
Issuing Company UCB S.A.
Report Type Integrated Report
Report Language EN
Report Filesize 10.3 MB
No. of Pages 288 pages
Reporting periodJanuary 1, 2018-December 31, 2018
Report EditionUnknown
Assurance Provider Independent Limited Assurance Report
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue
